Profile data is unavailable for this security.
About the company
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
- Revenue in USD (TTM)1.31m
- Net income in USD-14.73m
- Incorporated2014
- Employees5.00
- LocationAvalon Globocare Corp4400 ROUTE 9, SUITE 3100FREEHOLD 07728United StatesUSA
- Phone+1 (732) 780-4400
- Fax+1 (732) 780-5600
- Websitehttp://www.avalon-globocare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPO Global Inc | 838.00k | -540.00k | 617.35k | 2.00 | -- | -- | -- | 0.7367 | -85.99 | -85.99 | 131.76 | -476.56 | 1.76 | -- | -- | -- | -113.56 | -305.39 | -- | -- | 31.15 | 27.31 | -64.44 | -384.85 | -- | -1.45 | -- | -- | -17.09 | -15.13 | 13.03 | -- | -- | -- |
Modern Mobility Aids Inc | 0.00 | -1.59m | 1.01m | -- | -- | -- | -- | -- | -0.0177 | -0.0177 | 0.00 | -0.004 | 0.00 | -- | -- | -- | -4,668.68 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -371.94 | -- | -- | -- |
Novo Integrated Sciences Inc | 13.52m | -24.33m | 1.05m | 127.00 | -- | 0.1053 | -- | 0.0775 | -1.38 | -1.38 | 0.7955 | 0.5225 | 0.3804 | 8.21 | 7.55 | 106,432.80 | -68.51 | -29.43 | -113.88 | -35.64 | 37.68 | 39.59 | -180.11 | -110.25 | 0.2227 | -0.6679 | 0.2093 | -- | 7.11 | 7.17 | 59.77 | -- | -22.73 | -- |
IMAC Holdings Inc | 0.00 | -5.63m | 1.93m | 2.00 | -- | -- | -- | -- | -5.04 | -5.46 | 0.00 | -1.08 | 0.00 | -- | 0.00 | 0.00 | -166.65 | -48.88 | -1,050.71 | -70.25 | -- | -- | -- | -97.63 | -- | -14.97 | -- | -- | -- | -- | 45.27 | -- | -- | -- |
Caremax Inc | 784.55m | -782.86m | 2.54m | 1.45k | -- | -- | -- | 0.0032 | -208.41 | -208.41 | 208.34 | -38.73 | 0.9776 | -- | 6.10 | 541,069.60 | -97.55 | -- | -160.21 | -- | -3.31 | -- | -99.78 | -- | -- | -1.95 | 1.57 | -- | 19.01 | -- | -1,707.99 | -- | -- | -- |
Greenbrook TMS Inc | 75.21m | -52.20m | 2.63m | 629.00 | -- | -- | -- | 0.035 | -1.20 | -1.20 | 1.72 | -2.71 | 1.33 | -- | 8.73 | -- | -93.25 | -68.51 | -206.71 | -106.45 | 28.27 | 38.65 | -70.09 | -76.82 | -- | -1.99 | 20.04 | -- | 10.42 | 28.26 | 44.21 | -- | -54.79 | -- |
Avalon Globocare Corp | 1.31m | -14.73m | 2.82m | 5.00 | -- | -- | -- | 2.16 | -19.56 | -19.56 | 1.67 | 4.94 | 0.0529 | -- | 13.47 | 261,792.00 | -59.51 | -100.94 | -96.64 | -134.51 | 21.33 | 24.44 | -1,125.62 | -1,011.06 | -- | -0.3286 | 0.6162 | -- | 4.45 | -4.28 | -40.03 | -- | -51.83 | -- |
Mitesco Inc | 6.00k | -4.15m | 3.29m | 3.00 | -- | -- | -- | 548.75 | -0.6434 | -0.6121 | 0.0004 | -2.54 | 0.0332 | -- | -- | 2,000.00 | -1,094.48 | -246.54 | -- | -- | 0.00 | -- | -33,009.50 | -29,214.62 | -- | -0.7877 | -- | -- | -- | -- | -59.12 | -- | -- | -- |
Syra Health Corp | 7.74m | -4.25m | 3.71m | 78.00 | -- | 1.11 | -- | 0.4789 | -0.6471 | -0.6471 | 1.16 | 0.3396 | 2.20 | -- | 7.98 | 99,250.77 | -120.88 | -- | -225.30 | -- | 22.99 | -- | -54.90 | -- | -- | -5,665.83 | 0.0673 | -- | -1.83 | -- | -38.72 | -- | -- | -- |
Ethema Health Corp | 5.68m | -2.13m | 3.86m | 65.00 | -- | -- | -- | 0.6809 | -0.0005 | -0.0005 | 0.0012 | -0.0009 | 0.4666 | -- | 10.68 | 87,311.84 | -20.83 | -37.68 | -57.76 | -- | -- | -- | -44.64 | -94.87 | -- | -2.33 | -- | -- | 10.87 | 65.34 | 652.41 | -- | 74.97 | -- |
Selectis Health Inc | 38.30m | -5.51m | 4.17m | 574.00 | -- | -- | -- | 0.1089 | -1.80 | -1.80 | 12.50 | -1.58 | 1.00 | -- | 19.48 | 66,719.06 | -14.37 | -3.03 | -26.50 | -3.58 | -- | -- | -14.31 | -4.84 | -- | -2.37 | 1.18 | -- | -9.40 | 58.97 | -64.93 | -- | -47.72 | -- |
Holder | Shares | % Held |
---|---|---|
Citadel Securities LLCas of 30 Sep 2024 | 2.54k | 0.24% |
The Vanguard Group, Inc.as of 30 Sep 2024 | 2.30k | 0.22% |
Geode Capital Management LLCas of 30 Sep 2024 | 2.14k | 0.20% |
HRT Financial LP (US)as of 30 Sep 2024 | 1.80k | 0.17% |
SSgA Funds Management, Inc.as of 30 Sep 2024 | 1.28k | 0.12% |
Jane Street Capital LLCas of 30 Sep 2024 | 924.00 | 0.09% |
XTX Markets LLCas of 30 Sep 2024 | 814.00 | 0.08% |
UBS Securities LLCas of 30 Sep 2024 | 604.00 | 0.06% |
Tower Research Capital LLCas of 30 Sep 2024 | 285.00 | 0.03% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 2024 | 13.00 | 0.00% |